Abstrait
Les infections pelviennes graves de la femme constituent la forme la plus sévère d’une maladie appelée « maladie inflammatoire du pelvis » ou encore « pelvic inflammatory disease (PID) » par les Anglo-Saxons (1). Cette affection, que nous connaissons plus généralement sous le terme générique d’infection génitale haute, fait référence à toute infection de l’utérus, des trompes ou des structures pelviennes adjacentes en dehors d’un contexte chirurgical ou de la grossesse. Elle regroupe l’endocervicite, l’endométrite et la salpingite. L’endocervicite correspond à l’infection du canal cervical au-delà de l’orifice externe, l’endométrite à l’infection localisée de l’utérus, et la salpingite à l’atteinte utéro-annexielle. Malgré ces distinctions nosologiques, l’ensemble de ces pathologies représente une seule entité, avec une prise en charge très similaire dans le cadre des maladies sexuellement transmissibles (MST). Il s’agit d’une affection fréquente (1 million de cas par an aux États-Unis) qui génère des complications (douleurs chroniques, grossesse extra-utérine [GEU], infertilité) et des coûts très importants (1 milliard $ par an aux mêmes États-Unis) (2).
Preview
Unable to display preview. Download preview PDF.
Références
McCormack WM (1994) Pelvic inflammatory disease. N Engl J Med 330: 115–9
Crossman SH (2006) The challenge of pelvic inflammatory disease. Am Fam Physician 73: 859–64
Rivlin ME, Hunt JA (1986) Surgical management of diffuse peritonitis complicating obstetric/gynecologic infections. Obstet Gynecol 67: 652–6
Ross JD (2003) Pelvic inflammatory disease: how should it be managed? Curr Opin Infect Dis 16: 37–41
Ripa T (1990) Epidemiologic control of genital Chlamydia trachomatis infections. Scand J Infect Dis Suppl 69: 157–67
Peterson HB, Walker CK, Kahn JG et al. (1991) Pelvic inflammatory disease. Key treatment issues and options. JAMA 266: 2605–11
Kahn JG, Walker CK, Washington AE et al. (1991) Sweet RL. Diagnosing pelvic inflammatory disease. A comprehensive analysis and considerations for developing a new model. Jama 266: 2594–604
Ravolamanana Ralisata L, Rabenjamina FR, Razafintsalama DL, el al. (2001) Post-abortum peritonitis pelviperitonitis at the Androva Mahajanga University Hospital: 23 cases. J Gynecol Obstet Biol Reprod (Paris) 30: 282–7
Sood M, Juneja Y, Goyal U (1995) Maternal mortality and morbidity associated with clandestine abortions. J Indian Med Assoc 93: 77–9
Jonsson M, Karlsson R, Rylander E et al. (1997) The associations between risk behaviour and reported history of sexually transmitted diseases, among young women: a population-based study. Int J STD AIDS 8: 501–5
Brook I (2002) Microbiology and management of polymicrobial female genital tract infections in adolescents. J Pediatr Adolesc Gynecol 15: 217–26
Walker CK, Workowski KA, Washington AE et al. (1999) Anaerobes in pelvic inflammatory disease: implications for the Centers for Disease Control and Prevention’s guidelines for treatment of sexually transmitted diseases. Clin Infect Dis 28Suppl 1: S29–36
Peipert JF (2003) Clinical practice. Genital chlamydial infections. N Engl J Med 349: 2424–30
Herida M, Sednaoui P, Goulet V (2004) Gonorrhoea surveillance system in France: 1986–2000. Sex Transm Dis 31: 209–14
Barbosa C, Macasaet M, Brockmann S et al. (1997) Pelvic inflammatory disease and human immunodeficiency virus infection. Obstet Gynecol 89: 65–70
Farley TM, Rosenberg MJ, Rowe PJ et al. (1992) Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 339: 785–8
Apuzzio JJ, Hessami S, Rodriguez P (2001) Blood cultures for women hospitalized with acute pelvic inflammatory disease. Are they necessary? J Reprod Med 46: 815–8
Horrow MM (2004) Ultrasound of pelvic inflammatory disease. Ultrasound Q 20: 171–9
Tepper R, Aviram R, Cohen N et al. (1998) Doppler flow characteristics in patients with pelvic inflammatory disease: responders versus nonresponders to therapy. J Clin Ultrasound 26: 247–9
Sam JW, Jacobs JE, Birnbaum BA (2002) Spectrum of CT findings in acute pyogenic pelvic inflammatory disease. Radiographics 22: 1327–34
Worthen NJ, Gunning JE (1986) Percutaneous drainage of pelvic abscesses: management of the tubo-ovarian abscess. J Ultrasound Med 5: 551–6
Gjelland K, Ekerhovd E, Granberg S (2005) Transvaginal ultrasound-guided aspiration for treatment of tubo-ovarian abscess: a study of 302 cases. Am J Obstet Gynecol 193: 1323–30
Teisala K, Heinonen PK, Punnonen R (1990) Laparoscopic diagnosis and treatment of acute pyosalpinx. J Reprod Med 35: 19–21
McNeeley SG, Hendrix SL, Mazzoni MM et al. (1998) Medically sound, cost-effective treatment for pelvic inflammatory disease and tuboovarian abscess. Am J Obstet Gynecol 178: 1272–8
Loos W, Rath W, von Hugo R et al. (1989) Septic ovarian vein thrombosis-diagnosis and therapy. Arch Gynecol Obstet 245: 827–9
Ness RB, Soper DE, Holley RL et al. (2002) Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. Am J Obstet Gynecol 186: 929–37
Ness RB, Trautmann G, Richter HE et al. (2005) Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial. Obstet Gynecol 106: 573–80
Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002; 51(RR-6): 1–78
Ghanem KG, Giles JA, Zenilman JM (2005) Fluoroquinolone-resistant Neisseria gonorrhoeae: the inevitable epidemic. Infect Dis Clin North Am 19: 351–65
Martin IM, Ison CA, Aanensen DM et al. (2005) Changing epidemiologic profile of quinolone-resistant Neisseria gonorrhoeae in London. J Infect Dis 192: 1191–5
Cazzola D (1980) Further trials of anti-inflammatory agents in inflammatory gynecological diseases. Ann Ostet Ginecol Med Perinat 101: 426–42
Bassil S, Le Bouedec G, Mage G et al. (1991) The role of anti-inflammatory agents in the treatment of acute salpingitis. A randomized study of 40 patients with celioscopic control. J Gynecol Obstet Biol Reprod (Paris) 20: 1063–7
Landers DV, Sung ML, Bottles K, Schachter J (1993) Does addition of anti-inflammatory agents to antimicrobial therapy reduce infertility after murine chlamydial salpingitis? Sex Transm Dis 20: 121–5
Patton DL, Sweeney YC, Bohannon NJ et al. (1997) Effects of doxycycline and anti-inflammatory agents on experimentally induced chlamydial upper genital tract infection in female macaques. J Infect Dis 175: 648–54
Verhoest P, Orfila J, Bissac E (1997) Use of an experimental Chlamydia trachomatis salpingitis model for evaluating the effectiveness of antibiotics and anti-inflammatory agents on fertility. J Gynecol Obstet Biol Reprod (Paris) 26: 309–14
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag France
About this chapter
Cite this chapter
Verroust, N., Mignon, A. (2007). Infections pelviennes graves de la femme. In: Mallédant, Y., Seguin, P. (eds) Les infections intra-abdominales aiguës. Le point sur …. Springer, Paris. https://doi.org/10.1007/978-2-287-69814-9_6
Download citation
DOI: https://doi.org/10.1007/978-2-287-69814-9_6
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-69812-5
Online ISBN: 978-2-287-69814-9